Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2021

04.03.2021 | Original Article

Comparison of Fetomaternal Outcome Between Planned Vaginal Delivery and Planned Cesarean Section in Women with Eclampsia: Observational Study

verfasst von: Snehamay Chaudhuri, Dipak Kumar Giri, Arpita Mondal, Rashmi Rani, Vaitheeswari Janani, Malay Mundle

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

The route of termination of pregnancy in eclampsia is not clearly established. This study aims to compare the fetomaternal outcome between planned vaginal delivery and planned cesarean section in women with eclampsia after 34 weeks of gestation.

Methods

This prospective observational study was conducted in the department of Obstetrics and Gynecology, Midnapore Medical College, West Bengal, India. 182 women with eclampsia carrying 34 weeks or more gestation were allocated to either cesarean(CD) or vaginal delivery (VD) group. The primary measure of outcome was severe maternal outcome. Secondary measures of outcome were perinatal mortality and morbidity.

Results

Of the 62 women allocated in vaginal delivery (VD) group, 60 women (32.97%) had vaginal delivery and 122 (67.03%) had undergone cesarean delivery (CD). Severe maternal outcome was more common in VD group in comparison with CD group (72.5% vs 27.5%, P < 0.00001 RR 2.64 OR 6.98). Perinatal outcome in relation to Apgar score at 5 min, still birth was better in CD group than VD group. Perinatal death was higher in VD group when compared with CD group (25.8%; vs. 8.33%; P = 0.002, RR 3.1 OR 3.83)

Conclusion

There is increasing trend of delivering the eclampsia mother at > 34 weeks of gestation by cesarean section instead of inducing labor and delivering vaginally. Cesarean section when chosen as method of delivery does not increase morbidity or mortality.
Literatur
2.
Zurück zum Zitat Nobis PN, Hajong A. Eclampsia in India through decades. J Obstet Gynecol India. 2016;66(S1):S172–6.CrossRef Nobis PN, Hajong A. Eclampsia in India through decades. J Obstet Gynecol India. 2016;66(S1):S172–6.CrossRef
4.
Zurück zum Zitat Begum N, Jahan S, Ganguly S, et al. Fetomaternal outcome of vaginal delivery and cesarean section in eclamptic women. J Dhaka Med Coll. 2015;24(2):92–8.CrossRef Begum N, Jahan S, Ganguly S, et al. Fetomaternal outcome of vaginal delivery and cesarean section in eclamptic women. J Dhaka Med Coll. 2015;24(2):92–8.CrossRef
5.
Zurück zum Zitat Saeed G, Wajid R, Dar AY. Maternal mortality in eclampsia after cesarean section versus vaginal delivery. Ann King Edward Med Univ. 2017;23(4):446–50. Saeed G, Wajid R, Dar AY. Maternal mortality in eclampsia after cesarean section versus vaginal delivery. Ann King Edward Med Univ. 2017;23(4):446–50.
6.
Zurück zum Zitat Kumari P, Singh S, Khatun S. Comparative study of vaginal delivery and caesarean section in antepartum eclampsia at tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017;6:457–60.CrossRef Kumari P, Singh S, Khatun S. Comparative study of vaginal delivery and caesarean section in antepartum eclampsia at tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017;6:457–60.CrossRef
7.
Zurück zum Zitat Tukur J, Umar NI, Khan N, et al. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med. 2007;16:364–7.CrossRef Tukur J, Umar NI, Khan N, et al. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med. 2007;16:364–7.CrossRef
8.
Zurück zum Zitat Seal SL, Ghosh D, Kamilya G, et al. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012;206(6):484.e1-484.e7.CrossRef Seal SL, Ghosh D, Kamilya G, et al. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012;206(6):484.e1-484.e7.CrossRef
9.
Zurück zum Zitat Mathai M, Sanghvi H, Guidotti RJ. Major contributors. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. Geneva: Department of Reproductive Health and Research, World Health Organization; 2000. p. S43. Mathai M, Sanghvi H, Guidotti RJ. Major contributors. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. Geneva: Department of Reproductive Health and Research, World Health Organization; 2000. p. S43.
10.
Zurück zum Zitat Singh A, Shrivastava C. Changing trends in eclampsia and increasing cesarean delivery—an interesting retrospective study from a tertiary care hospital of Raipur, Chhattisgarh, India. Int J Reprod Contracept Obstet Gynecol. 2016;5:1031–5.CrossRef Singh A, Shrivastava C. Changing trends in eclampsia and increasing cesarean delivery—an interesting retrospective study from a tertiary care hospital of Raipur, Chhattisgarh, India. Int J Reprod Contracept Obstet Gynecol. 2016;5:1031–5.CrossRef
11.
Zurück zum Zitat Vousden N, Lawley E, Seed PT, et al. Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomized controlled trial. PLoS Med. 2019;16(3):e1002775.CrossRef Vousden N, Lawley E, Seed PT, et al. Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomized controlled trial. PLoS Med. 2019;16(3):e1002775.CrossRef
12.
Zurück zum Zitat Das R, Biswas S. Eclampsia: the major cause of maternal mortality in eastern India. Ethiop J Health Sci. 2015;25(2):111–6.CrossRef Das R, Biswas S. Eclampsia: the major cause of maternal mortality in eastern India. Ethiop J Health Sci. 2015;25(2):111–6.CrossRef
13.
Zurück zum Zitat Chaudhuri S, Nath S. Life-threatening complications in pregnancy in a teaching hospital in Kolkata, India. J Obstet Gynecol India. 2019;69(2):15–22.CrossRef Chaudhuri S, Nath S. Life-threatening complications in pregnancy in a teaching hospital in Kolkata, India. J Obstet Gynecol India. 2019;69(2):15–22.CrossRef
14.
Zurück zum Zitat Abalos E, Cuesta C, Carroli G, et al. On behalf of the WHO multicountry survey on maternal and newborn health research network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl. 1):14–24.CrossRef Abalos E, Cuesta C, Carroli G, et al. On behalf of the WHO multicountry survey on maternal and newborn health research network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl. 1):14–24.CrossRef
Metadaten
Titel
Comparison of Fetomaternal Outcome Between Planned Vaginal Delivery and Planned Cesarean Section in Women with Eclampsia: Observational Study
verfasst von
Snehamay Chaudhuri
Dipak Kumar Giri
Arpita Mondal
Rashmi Rani
Vaitheeswari Janani
Malay Mundle
Publikationsdatum
04.03.2021
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2021
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-021-01432-x

Weitere Artikel der Ausgabe 4/2021

The Journal of Obstetrics and Gynecology of India 4/2021 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.